Skip to content

Clinical trials

Completed Phase 3 Anxiety Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 3 Status: Completed Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20022
20035
200411
200511
200615
20072
200811
20095
20104
20116
20127
20136
20141
20151
20163
20171
20191
20201
20222
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed104

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
AstraZeneca6
Sanofi6
Karolinska Institutet5
Takeda4
Otsuka Pharmaceutical Development & Commercialization, Inc.3
University of Pennsylvania3
Alliance for Clinical Trials in Oncology2
Cephalon2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders104
Generalized Anxiety Disorder23
Phobia, Social9
Stress Disorders, Post-Traumatic8
Pain6
Major Depressive Disorder5
Mental Disorders5
Stress Disorders, Traumatic5
Sleep Initiation and Maintenance Disorders4
Attention Deficit Disorder with Hyperactivity3

Trials

Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.